{"originalText": "，2014.6体检发现肝多发转移，肠镜提示乙状结肠癌，2014.7.10行原发灶切除术，2014-8-6开始行7周期XELOX+BEV化疗，2014-12-30复查腹部MRI提示肝脏病灶较前略缩小。胸部CR未见异常。治疗期间神经炎2度。后换用希罗达+BEV维持治疗7周期，末次化疗时间2015-6-15，患者耐受性可。2015.5.11复查肿瘤标志物提示CEA较前升高，2015.5.7复查MRI提示肝转移变化不大。2015.7复查CEA较前增长，2015-7-6给予XELOX+BEV化疗2CS。，2015-7-10盆腔MRI:乙状结肠术后改变，局部未见复发征象。化验血常规、肝肾功指标正常。2015-07-15，腹腔MRI与2015-05-07腹部MR对比：肝脏多发转移瘤较前略缩小。2015.9复查CT提示病灶稳定，2015.9.28换为BEV+XELODA维持治疗至今。现患者精神食欲可，大小便正常，体重近期无变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 16}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 21, "end_pos": 26}, {"end_pos": 67, "label_type": "药物", "overlap": 0, "start_pos": 64}, {"label_type": "影像检查", "overlap": 0, "start_pos": 82, "end_pos": 87}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "影像检查", "overlap": 0, "start_pos": 99, "end_pos": 103}, {"end_pos": 124, "label_type": "药物", "overlap": 0, "start_pos": 121}, {"end_pos": 128, "label_type": "药物", "overlap": 0, "start_pos": 125}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 177, "end_pos": 180}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 195, "end_pos": 198}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 216, "end_pos": 219}, {"end_pos": 243, "label_type": "药物", "overlap": 0, "start_pos": 240}, {"label_type": "影像检查", "overlap": 0, "start_pos": 259, "end_pos": 264}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 265, "end_pos": 271}, {"label_type": "影像检查", "overlap": 0, "start_pos": 308, "end_pos": 313}, {"label_type": "影像检查", "overlap": 0, "start_pos": 324, "end_pos": 328}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 331, "end_pos": 338}, {"label_type": "影像检查", "overlap": 0, "start_pos": 352, "end_pos": 354}, {"end_pos": 375, "label_type": "药物", "overlap": 0, "start_pos": 372}, {"end_pos": 382, "label_type": "药物", "overlap": 0, "start_pos": 376}]}
